- A Study on the Efficacy and Safety of Rivaroxaban in Urologic Cancer-Associated Venous Thromboembolism
-
Lee JH, You D, Lee SD, Oh YM, Lee JS
- KMID: 2470403
- Korean J Urol Oncol.
- 2019 Dec;17(3):178-185.
- doi: 10.22465/kjuo.2019.17.3.178
PURPOSE: Although direct oral anticoagulants (DOACs) are recommended as an alternative to low-molecular weighted heparin for cancer-associated venous thromboembolism (VTE), there is no firm evidence on the efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
-
Hong KS
- KMID: 2464644
- J Stroke.
- 2019 Sep;21(3):259-275.
- doi: 10.5853/jos.2019.01970
Non-Vitamin K antagonist oral anticoagulants (NOACs) have been extensively investigated in medical conditions at high risk of venous or arterial thrombosis other than atrial fibrillation (AF), including hip or knee... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
-
Yhim HY, Choi WI, Kim SH, Nam SH, Kim KH, Mun YC, Oh D, Hwang HG, Lee KW, Song EK, Kwon YS, Bang SM
- KMID: 2457036
- Korean J Intern Med.
- 2019 Sep;34(5):1125-1135.
- doi: 10.3904/kjim.2018.097
BACKGROUND/AIMS: Limited data are available regarding the efficacy of rivaroxaban for the treatment of cancer-associated venous thromboembolism (VTE). The aim of this study was to evaluate the effectiveness and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Is the Oral Chemical Prophylaxis Necessary for the Prevention of Venous Thromboembolism after Joint Arthroplasty in a Korean Population?
-
Moon KH, Kang JS, Youn YH
- KMID: 2455988
- Hip Pelvis.
- 2019 Sep;31(3):150-157.
- doi: 10.5371/hp.2019.31.3.150
PURPOSE: Venous thromboembolism (VTE) is a serious complication that may occur after a major orthopedic surgery. The aim of the present study was to determine the necessity of a chemical... -
- CITED
-
- Close
- SHARE
-
- Close
- Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
-
Lee JH, Oh YM, Lee SD, Lee JS
- KMID: 2456269
- J Korean Med Sci.
- 2019 Jun;34(21):e160.
- doi: 10.3346/jkms.2019.34.e160
BACKGROUND: Low-molecular-weight heparin (LMWH) is the standard treatment for venous thromboembolism (VTE) in patients with active cancer. However, use of factor Xa inhibitors, such as rivaroxaban, is increasing on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
-
Lee SR, Lee YS, Park JS, Cha MJ, Kim TH, Park J, Park JK, Lee JM, Kang KW, Shim J, Uhm JS, Kim J, Kim C, Kim JB, Park HW, Joung B, Choi EK
- KMID: 2441305
- Yonsei Med J.
- 2019 Mar;60(3):277-284.
- doi: 10.3349/ymj.2019.60.3.277
PURPOSE: Label adherence for non-vitamin K antagonist oral anticoagulants (NOACs) has not been well evaluated in Asian patients with non-valvular atrial fibrillation (AF). The present study aimed to assess label... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
-
Kim H, Kim H, Cho SK, Kim JB, Joung B, Kim C
- KMID: 2438536
- Korean Circ J.
- 2019 Mar;49(3):252-263.
- doi: 10.4070/kcj.2018.0220
BACKGROUND AND OBJECTIVES: Rivaroxaban is noninferior to warfarin for preventing stroke or systemic embolism in patients with high-risk atrial fibrillation (AF) and is associated with a lower rate of intracranial... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidural hematoma after total knee arthroplasty in a patient receiving rivaroxaban: A case report
-
Shin S, Kang H, Lee JW, Kim HG, Choi ES
- KMID: 2434207
- Anesth Pain Med.
- 2019 Jan;14(1):102-105.
- doi: 10.17085/apm.2019.14.1.102
Rivaroxaban, a factor Xa inhibitor, is one of the newly developed direct oral anticoagulants (DOAC). In recent times, it has been increasingly used in the prevention of pulmonary embolism in... -
- CITED
-
- Close
- SHARE
-
- Close
- Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis
-
Jeong HK, Lee KH, Park HW, Yoon NS, Kim MC, Lee N, Kim JS, Ahn Y, Jeong MH, Park JC, Cho JG
- KMID: 2432256
- Chonnam Med J.
- 2019 Jan;55(1):54-61.
- doi: 10.4068/cmj.2019.55.1.54
Rivaroxaban has emerged as a potential alternative to warfarin for the prevention of thromboembolism in patients with atrial fibrillation (AF). However, there has been concern for the risk of major... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
-
Lee JY
- KMID: 2428008
- Korean J Helicobacter Up Gastrointest Res.
- 2018 Dec;18(4):219-224.
- doi: 10.7704/kjhugr.2018.18.4.219
New oral anticoagulants (NOACs) are now widely used for the prevention and treatment of venous thrombosis, and for the prevention of stroke and systemic embolism in patients with atrial fibrillation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
-
Steiner T, Köhrmann , Schellinger PD, Tsivgoulis G
- KMID: 2428765
- J Stroke.
- 2018 Sep;20(3):292-301.
- doi: 10.5853/jos.2018.02250
Oral anticoagulant-associated intracerebral hemorrhage (OAC-ICH) accounts for nearly 20% of all ICH. The number of patients with an indication for oral anticoagulant therapy (OAT) increases with increasing age. OAT became... -
- CITED
-
- Close
- SHARE
-
- Close
- Rivaroxaban and Acetylsalicylic Acid for Prevention of Venous Thromboembolism Following Total Knee Arthroplasty in Korean Patients
-
Chung KS, Shin TY, Park SH, Kim H, Choi CH
- KMID: 2420351
- Knee Surg Relat Res.
- 2018 Sep;30(3):247-254.
- doi: 10.5792/ksrr.17.092
PURPOSE: To investigate the incidence of venous thromboembolism (VTE) after total knee arthroplasty (TKA) with chemoprophylaxis using acetylsalicylic acid (AA) or rivaroxaban in Korean patients. MATERIALS AND METHODS: Between May 2011... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of the Health Insurance Coverage Policy on Oral Anticoagulant Prescription among Patients with Atrial Fibrillation in Korea from 2014 to 2016
-
Ko YJ, Kim S, Park K, Kim M, Yang BR, Kim MS, Lee J, Park BJ
- KMID: 2415445
- J Korean Med Sci.
- 2018 Jun;33(23):e163.
- doi: 10.3346/jkms.2018.33.e163
BACKGROUND: To evaluate oral anticoagulant (OAC) utilization in patients with atrial fibrillation after the changes in the health insurance coverage policy in July 2015. METHODS: We used the Health Insurance Review... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation
-
Patel MR, Peacock WF, Tamayo S, Sicignano , Hopf KP, Yuan Z
- KMID: 2409818
- Clin Exp Emerg Med.
- 2018 Mar;5(1):43-50.
- doi: 10.15441/ceem.17.216
OBJECTIVE: Patients with nonvalvular atrial fibrillation (AF) and renal disease (RD) who receive anticoagulation therapy appear to be at greater risk of major bleeding (MB) than AF patients without RD.... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Spinal Subdural Hematoma in a Patient Taking Rivaroxaban
-
Bang WS, Kim KT, Park MK, Sung JK, Lee H, Cho DC
- KMID: 2401702
- J Korean Med Sci.
- 2018 Jan;33(5):e40.
- doi: 10.3346/jkms.2018.33.e40
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary artery sarcoma manifesting as a main pulmonary artery stenosis diagnosed by 18F-FDG PET/CT
-
Lee H, Park HB, Cho YK, Ahn JM, Lee SM, Lee JS, Kim DH
- KMID: 2400368
- Yeungnam Univ J Med.
- 2017 Dec;34(2):279-284.
- doi: 10.12701/yujm.2017.34.2.279
Pulmonary artery sarcoma (PAS) is a rare and fatal disease that often mimics chronic thromboembolic pulmonary hypertension (CTEPH); therefore, diagnosis of PAS is often delayed. Herein, a healthy 74-year-old man... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients
-
Joung B
- KMID: 2396475
- Korean Circ J.
- 2017 Nov;47(6):833-841.
- doi: 10.4070/kcj.2017.0158
Regulatory approvals of non-vitamin K antagonist oral anticoagulants (NOACs) have been based on large randomized phase III trials evaluating dabigatran, rivaroxaban, apixaban, or edoxaban relative to warfarin for atrial fibrillation... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
-
Seiffge DJ, Traenka C, Polymeris , Thilemann , Wagner B, Hert L, Müller MD, Gensicke H, Peters N, Nickel CH, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis GM, Lyrer PA, Bonati LH, Tsakiris D, Engelter S
- KMID: 2408401
- J Stroke.
- 2017 Sep;19(3):347-355.
- doi: 10.5853/jos.2017.00395
BACKGROUND AND PURPOSE: Standard operating procedures (SOP) incorporating plasma levels of rivaroxaban might be helpful in selecting patients with acute ischemic stroke taking rivaroxaban suitable for IVthrombolysis (IVT) or endovascular... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
-
Rhew SH, Kim SS
- KMID: 2390933
- Transl Clin Pharmacol.
- 2017 Sep;25(3):138-140.
- doi: 10.12793/tcp.2017.25.3.138
Rivaroxaban is a new oral anticoagulant used for the prevention of stroke in patients with atrial fibrillation. Hemorrhagic pericarditis is known to occur with rivaroxaban; however, only a few case... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Novel Oral Anticoagulant to Treat Pulmonary Thromboembolism in Patient with Ulcerative Colitis Superinfected Cytomegalovirus Colitis
-
Kim SH, Jang S, Sung Y, Park JK, Park Y, Yun J, Kang SB
- KMID: 2390784
- Korean J Gastroenterol.
- 2017 Jul;70(1):44-49.
- doi: 10.4166/kjg.2017.70.1.44
Crohn's disease and ulcerative colitis are the two major types of inflammatory bowel disease, and affect mainly the gastrointestinal tract but also have extraintestinal sequelae, such as arterial and venous... -
- CITED
-
- Close
- SHARE
-
- Close
